Skip to main content
Full access
Clinical and Research Reports
Published Online: 16 July 2020

Presymptomatic Testing and Confidentiality in the Age of the Electronic Medical Record

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

Objective:

Recent introduction of a commercial electronic medical record (EMR) system at the authors’ institution raised a number of questions about documenting visits for presymptomatic testing for Huntington’s disease (HD). Specifically, adoption of the EMR potentially compromised patient confidentiality and the personal delivery of test results, both of which are strongly recommended by professional consensus and lay organizations.

Methods:

The authors surveyed peer institutions about their experience with EMR systems in the setting of presymptomatic testing for HD.

Results:

Answers from 10 well-known HD specialty centers demonstrated a wide variety of approaches to managing these concerns. The responses did not clarify how to resolve the collision between the virtues of a shared medical record and the goal of patient control of sensitive medical information.

Conclusions:

These results demonstrate that important issues remain unresolved. The authors propose that medical record systems must adapt to and respect the patient’s desires for confidentiality and allow people undergoing presymptomatic testing to restrict access to this sensitive information.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 80 - 83
PubMed: 32669021

History

Received: 17 April 2020
Accepted: 5 June 2020
Published online: 16 July 2020
Published in print: Winter 2021

Keywords

  1. Access to Information
  2. Clinical Laboratory Services
  3. Privacy
  4. Genetic Testing
  5. Huntington’s Disease
  6. Electronic Medical Record

Authors

Details

Kevin J. Black, M.D., F.A.N.P.A. [email protected]
Departments of Psychiatry (Black), Neurology (Black, Barton, Perlmutter), Radiology (Black, Perlmutter), and Neuroscience (Black, Perlmutter), and Programs in Physical Therapy and Occupational Therapy (Perlmutter), Washington University School of Medicine, St. Louis.
Stacey K. Barton, M.S.W., L.C.S.W.
Departments of Psychiatry (Black), Neurology (Black, Barton, Perlmutter), Radiology (Black, Perlmutter), and Neuroscience (Black, Perlmutter), and Programs in Physical Therapy and Occupational Therapy (Perlmutter), Washington University School of Medicine, St. Louis.
Joel S. Perlmutter, M.D.
Departments of Psychiatry (Black), Neurology (Black, Barton, Perlmutter), Radiology (Black, Perlmutter), and Neuroscience (Black, Perlmutter), and Programs in Physical Therapy and Occupational Therapy (Perlmutter), Washington University School of Medicine, St. Louis.

Notes

Send correspondence to Dr. Black ([email protected]).

Competing Interests

Dr. Black has served as a consultant to Acadia Pharmaceuticals; he has received research grant support from Acadia Pharmaceuticals, Emalex Biosciences, and Neurocrine Biosciences; and he has served on the speaker’s bureaus of Acadia Pharmaceuticals and Teva Pharmaceuticals. The other authors report no financial relationships with commercial interests.

Funding Information

CHDI Foundationhttp://dx.doi.org/10.13039/100005725:
American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University:
Greater St. Louis Chapter of the APDA:
The Barnes-Jewish Hospital Foundation: Elliot Stein Family Fund, Parkinson Disease Research Fund
Huntington's Disease Society of Americahttp://dx.doi.org/10.13039/100000887:
The HDSA Center of Excellence at Washington University in St. Louis:
Supported in part by the American Parkinson Disease Association (APDA) Center for Advanced Parkinson Disease Research at Washington University School of Medicine, the Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund and Parkinson Disease Research Fund), the Cure Huntington’s Disease Initiative Foundation, the Greater St. Louis Chapter of the APDA, the Huntington’s Disease Society of America (HDSA), and the HDSA Center of Excellence at Washington University in St. Louis.The funders had no role in the study design, data collection, analysis, or decision to publish this article.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share